Filing Details

Accession Number:
0001209784-17-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-15 17:03:23
Reporting Period:
2017-02-13
Filing Date:
2017-02-15
Accepted Time:
2017-02-15 17:03:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1116463 Orasure Technologies Inc OSUR Surgical & Medical Instruments & Apparatus (3841) 364370966
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1209780 H Ronald Spair 220 East First Street
Bethlehem PA 18015
Coo & Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-13 15,794 $2.81 169,860 No 4 M Direct
Common Stock Disposition 2017-02-13 15,794 $10.59 154,066 No 4 S Direct
Common Stock Disposition 2017-02-13 38,678 $10.59 115,388 No 4 S Direct
Common Stock Acquisiton 2017-02-14 2,926 $2.81 118,314 No 4 M Direct
Common Stock Disposition 2017-02-14 2,926 $10.65 115,388 No 4 S Direct
Common Stock Disposition 2017-02-14 6,322 $10.65 109,066 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonqualified stock option Disposition 2017-02-13 15,794 $0.00 15,794 $2.81
Common Stock Nonqualified stock option Disposition 2017-02-14 2,926 $0.00 2,926 $2.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,926 2019-01-23 No 4 M Direct
0 2019-01-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 200,063 Indirect By Non-Qualified Deferred Compensation Plan
Footnotes
  1. Nonqualified stock options granted on January 23, 2009 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.